MTIP Fund II is fully compliant with Sustainable Finance Disclosure Regulation (SFDR) Art. 9 and has the status of a “dark green fund”. MTIP Fund II focuses on Healthtech Growth Capital Companies located or mainly active in Europe.
67%
Portfolio
ARR growth
in 2022
7/7
Number of invest-ments where MTIP is “Lead Investor”
MTIP Fund I already started our focus on healthcare technology, while also including legacy assets in medical devices. The stages we invested in were early- and late-stage venture capital, primarily in Europe and Israel.
32%
Portfolio
ARR growth
in 2022
6/8
Number of invest-ments where MTIP is “Lead Investor”